BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saito S, Lasky JA, Hagiwara K, Kondoh Y. Ethnic differences in idiopathic pulmonary fibrosis: The Japanese perspective. Respir Investig 2018;56:375-83. [PMID: 30061050 DOI: 10.1016/j.resinv.2018.06.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Uhara H, Tsuchida T, Kiyohara Y, Akamatsu A, Sakamoto T, Yamazaki N. Safety and effectiveness of nivolumab in Japanese patients with malignant melanoma: Final analysis of a post-marketing surveillance. J Dermatol 2022. [PMID: 35607248 DOI: 10.1111/1346-8138.16432] [Reference Citation Analysis]
2 Polke M, Kondoh Y, Wijsenbeek M, Cottin V, Walsh SLF, Collard HR, Chaudhuri N, Avdeev S, Behr J, Calligaro G, Corte TJ, Flaherty K, Funke-Chambour M, Kolb M, Krisam J, Maher TM, Molina Molina M, Morais A, Moor CC, Morisset J, Pereira C, Quadrelli S, Selman M, Tzouvelekis A, Valenzuela C, Vancheri C, Vicens-Zygmunt V, Wälscher J, Wuyts W, Bendstrup E, Kreuter M. Management of Acute Exacerbation of Idiopathic Pulmonary Fibrosis in Specialised and Non-specialised ILD Centres Around the World. Front Med (Lausanne) 2021;8:699644. [PMID: 34646836 DOI: 10.3389/fmed.2021.699644] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Iwasa E, Fujiyoshi Y, Kubota Y, Kimura R, Chandler RE, Taavola H, Norén GN, Wakao R. Interstitial Lung Disease as an Adverse Drug Reaction in Japan: Exploration of Regulatory Actions as a Basis for High Reporting. Drug Saf 2020;43:1121-31. [PMID: 32617874 DOI: 10.1007/s40264-020-00968-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
4 Isshiki T, Sakamoto S, Yamasaki A, Shimizu H, Miyoshi S, Nakamura Y, Homma S, Kishi K. Incidence of acute exacerbation of idiopathic pulmonary fibrosis in patients receiving antifibrotic agents: Real-world experience. Respir Med 2021;187:106551. [PMID: 34343721 DOI: 10.1016/j.rmed.2021.106551] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Kelly BT, Thao V, Dempsey TM, Sangaralingham LR, Payne SR, Teague TT, Moua T, Shah ND, Limper AH. Outcomes for hospitalized patients with idiopathic pulmonary fibrosis treated with antifibrotic medications. BMC Pulm Med 2021;21:239. [PMID: 34273943 DOI: 10.1186/s12890-021-01607-2] [Reference Citation Analysis]
6 Duchemann B, Pluvy J, Crestani B, Zalcman G, Nunes H. Immune checkpoint blockade for patients with lung cancer and idiopathic pulmonary fibrosis. Eur J Cancer 2021;145:179-82. [PMID: 33486441 DOI: 10.1016/j.ejca.2020.12.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Song JW, Ogura T, Inoue Y, Xu Z, Quaresma M, Stowasser S, Stansen W, Crestani B. Long-term treatment with nintedanib in Asian patients with idiopathic pulmonary fibrosis: Results from INPULSIS®-ON. Respirology 2020;25:410-6. [PMID: 31329360 DOI: 10.1111/resp.13647] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
8 Kishaba T. Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Medicina (Kaunas) 2019;55:E70. [PMID: 30884853 DOI: 10.3390/medicina55030070] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
9 Pesonen I, Ortiz C, Ferrara G. An Atypical Case of Idiopathic Pulmonary Fibrosis in a Patient from Africa. Medicina (Kaunas) 2019;55:E67. [PMID: 30875765 DOI: 10.3390/medicina55030067] [Reference Citation Analysis]
10 Kishaba T. New era of Idiopathic Pulmonary Fibrosis. Respir Investig 2018;56:427-9. [PMID: 30366836 DOI: 10.1016/j.resinv.2018.08.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Teramachi R, Kondoh Y, Kataoka K, Taniguchi H, Matsuda T, Kimura T, Yokoyama T, Yamano Y, Furukawa T, Sakamoto K, Hashimoto N, Hasegawa Y. Outcomes with newly proposed classification of acute respiratory deterioration in idiopathic pulmonary fibrosis. Respiratory Medicine 2018;143:147-52. [DOI: 10.1016/j.rmed.2018.09.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]